Since 5HT1B/1D antagonists can inhibit the CB1 modulation of nociceptive trigeminovascualr signals, triptans may induce their anti-migraine effects by activating endocannabinoid-containing neurons in the PAG.85 Here, CNR1 is linked to migraine disorder.